SPY422.11-2.37 -0.56%
DIA340.76-2.65 -0.77%
IXIC14,039.68-33.17 -0.24%

Xenon Pharmaceuticals Q1 EPS $(0.42) Misses $(0.40) Estimate, Sales $4.36M Miss $5.15M Estimate

Xenon Pharmaceuticals (NASDAQ:XENE) reported quarterly losses of $(0.42) per share which missed the analyst consensus estimate of $(0.40) by 5 percent. This is a 90.91 percent decrease over losses of $(0.22) per share

05/11/2021 16:14
Xenon Pharmaceuticals (NASDAQ:XENE) reported quarterly losses of $(0.42) per share which missed the analyst consensus estimate of $(0.40) by 5 percent. This is a 90.91 percent decrease over losses of $(0.22) per share from the same period last year. The company reported quarterly sales of $4.36 million which missed the analyst consensus estimate of $5.15 million by 15.38 percent. This is a 38.43 percent decrease over sales of $7.08 million the same period last year.